The role of ANRIL was evaluated in a study that identified connections between genetic variants (six SNPs in ANRIL) and risk of psoriasis in northern China; specific genotypes of high and low risk were described in the studied population [37]. Here, CDKN2B-AS1 is linked to psoriasis.